CONMED Corporation (CNMD)
CNMD trades on NYSE in Health Care, Biotechnology: Electromedical & Electrotherapeutic Apparatus. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:Revenues), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/816956/000081695626000009/0000816956-26-000009-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | CNMD on NYSE |
| Sector | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Country | United States |
| IPO year | 1987 |
| SEC CIK | 0000816956 |
| SEC industry code | Electromedical & Electrotherapeutic Apparatus |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $1.4B |
| Net income | $47.1M |
| Operating income | $102.6M |
| Net margin | 3.4% |
| Operating margin | 7.5% |
| Revenue growth | +5.2% |
| Cash | $40.8M |
| Total assets | $2.3B |
| P/E (computed) | 31.3× |
| P/S (computed) | 1.1× |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. | 10-Q 2026-10-28 |
| Cash and burn | $48.0M cash; operating cash flow $44.6M a quarter. | Report 2026-09-30 |
| Shares outstanding | 29,803,323 (2026-10-26); 30,967,954 a year earlier; 30,752,199 three years earlier. | Cover page 2026-10-26 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | PricewaterhouseCoopers LLP, Victor, New York, United States | PCAOB Form AP 2026-03-05 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $0, sold $161K on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q3 2026 2026-09-30 | $335.6M | $19.8M | $49.4M | $48.0M | $815.9M | Needs four quarters | 10-Q 2026-10-28 |
| Q2 2026 2026-06-30 | $343.5M | $23.1M | Not filed | $37.3M | $834.2M | Needs four quarters | 10-Q 2026-07-29 |
| Q4 2025 2025-12-31 | $373.2M | $16.7M | $46.3M | $40.8M | $834.9M | $1.4B | 10-K 2026-02-17 |
| Q3 2025 2025-09-30 | $337.9M | $2.9M | $53.7M | $38.9M | $853.8M | $1.3B | 10-Q 2026-10-28 |
| Q2 2025 2025-06-30 | $342.3M | $21.4M | $29.1M | $33.9M | $881.8M | $1.3B | 10-Q 2026-07-29 |
| Q1 2025 2025-03-31 | $321.3M | $6.0M | $41.5M | $35.5M | $892.2M | $1.3B | 10-Q 2025-05-01 |
| Q4 2024 2024-12-31 | $345.9M | $33.8M | $43.3M | $24.5M | $905.8M | $1.3B | 10-K 2026-02-17 |
| Q3 2024 2024-09-30 | $316.7M | $49.0M | $51.2M | $38.5M | $940.8M | $1.3B | 10-Q 2025-11-06 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest annual report | 10-K | 2026-02-17 |
| Latest quarterly / interim | 10-Q | 2026-10-28 |
| Latest current report | 8-K | 2026-10-28 |
| Latest proxy | DEFA14A | 2026-04-07 |
Source: SEC EDGAR submissions feed, 1,002 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -1.8% |
| 1 month | +11.1% |
| 3 months | +1.5% |
| Year to date | +24.6% |
| 1 year | +16.9% |
| From 52-week high | -5.7% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Electromedical & Electrotherapeutic Apparatus
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| CBLL | CeriBell Inc. | $26.42 | +1.07% | $1.0B |
| INMD | InMode Ltd. | $13.15 | -0.90% | $755.9M |
| TMDX | TransMedics Group Inc. | $92.21 | +0.91% | $3.2B |
| AXGN | Axogen Inc. | $55.38 | -0.98% | $3.3B |
| LIVN | LivaNova PLC | $92.44 | +1.23% | $5.1B |
| CV | CapsoVision Inc. | $6.47 | +7.30% | $346.9M |
| ELMD | Electromed Inc. | $23.10 | -5.02% | $188.8M |
| FOCL | EDAP TMS S.A. | $3.17 | -2.39% | $149.7M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier